Literature DB >> 27391861

Re-manufacture of cobalt-manganese-bromide as a liquid catalyst from spent catalyst containing cobalt generated from petrochemical processes via hydrometallurgy.

Sung-Ho Joo1, Dong Ju Shin2, Chang Hyun Oh2, Jei-Pil Wang3, Shun Myung Shin4.   

Abstract

Cobalt and manganese have been the subject of individual separation studies because their fields of application are different. However, this study shows that high-value products can be manufactured in the form of a cobalt-manganese-bromide (CMB) liquid catalyst by simultaneously recovering cobalt and manganese. Na-bis-(2,4,4-tri-methyl-pentyl)phosphinic acid was employed in order to manufacture the CMB liquid catalyst from the spent catalyst generated from petroleum chemistry processes. The pH-isotherm, degree of saponification of solvent and separation factor values were investigated. ΔpH50 and separation factor values show that Co and Mn can be separated from impurities such as Mg and Ca. Further, the extraction stages and organic/aqueous ratio isotherms were investigated using counter-current simulation extraction batch tests. To prepare CMB from a loaded organic phase obtained in a stripping study using hydrogen bromide, the Co and Mn were completely stripped and concentrated by a factor of 6 using a 2M hydrogen bromide solution. When compared with manufactured and commercial CMB, the CMB liquid catalyst could be produced by supplying a shortage of Mn in the form of manganese bromide. Finally, the method of manufacture of CMB was subjected to a real pilot plant test.
Copyright © 2016. Published by Elsevier B.V.

Entities:  

Keywords:  Cobalt; Hydrogen bromide; Manganese; Na-bis-(2,4,4-tri-methyl-pentyl)phosphinic acid

Year:  2016        PMID: 27391861     DOI: 10.1016/j.jhazmat.2016.06.008

Source DB:  PubMed          Journal:  J Hazard Mater        ISSN: 0304-3894            Impact factor:   10.588


  1 in total

1.  Influence of siloxane on the transport of ZnO nanoparticles from different release pathways in saturated sand.

Authors:  Sung Hee Joo; Marc Knecht; Chunming Su; Seokju Seo; Randy Lawrence
Journal:  RSC Adv       Date:  2016       Impact factor: 3.361

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.